RS60698B1 - Azitromicin derivativi sa osobinama poboljšanja epitelne barijere - Google Patents
Azitromicin derivativi sa osobinama poboljšanja epitelne barijereInfo
- Publication number
- RS60698B1 RS60698B1 RS20200947A RSP20200947A RS60698B1 RS 60698 B1 RS60698 B1 RS 60698B1 RS 20200947 A RS20200947 A RS 20200947A RS P20200947 A RSP20200947 A RS P20200947A RS 60698 B1 RS60698 B1 RS 60698B1
- Authority
- RS
- Serbia
- Prior art keywords
- alkyl
- oxy
- group
- heptamethyl
- ethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1520419.1A GB201520419D0 (en) | 2015-11-19 | 2015-11-19 | Compounds |
| EP16804720.7A EP3377511B1 (en) | 2015-11-19 | 2016-11-21 | Azithromycin derivatives with epithelial barrier enhancement properties |
| PCT/EP2016/078360 WO2017085329A1 (en) | 2015-11-19 | 2016-11-21 | Azithromycin derivatives with epithelial barrier enhancement properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS60698B1 true RS60698B1 (sr) | 2020-09-30 |
Family
ID=55133040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20200947A RS60698B1 (sr) | 2015-11-19 | 2016-11-21 | Azitromicin derivativi sa osobinama poboljšanja epitelne barijere |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US10723752B2 (https=) |
| EP (2) | EP3377511B1 (https=) |
| JP (2) | JP6849896B2 (https=) |
| KR (2) | KR20240157138A (https=) |
| CN (2) | CN108290919B (https=) |
| CA (1) | CA3005088A1 (https=) |
| CY (1) | CY1123418T1 (https=) |
| DK (1) | DK3377511T3 (https=) |
| ES (1) | ES2810703T3 (https=) |
| GB (1) | GB201520419D0 (https=) |
| HR (1) | HRP20201246T1 (https=) |
| HU (1) | HUE050307T2 (https=) |
| LT (1) | LT3377511T (https=) |
| PL (1) | PL3377511T3 (https=) |
| PT (1) | PT3377511T (https=) |
| RS (1) | RS60698B1 (https=) |
| SI (1) | SI3377511T1 (https=) |
| SM (1) | SMT202000426T1 (https=) |
| WO (1) | WO2017085329A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201520419D0 (en) | 2015-11-19 | 2016-01-06 | Epi Endo Pharmaceuticals Ehf | Compounds |
| KR20220156570A (ko) | 2020-03-12 | 2022-11-25 | 조에티스 서비시즈 엘엘씨 | 면역조절성 유레아 아잘라이드 |
| AU2022343476B2 (en) * | 2021-09-07 | 2025-02-20 | Zoetis Services Llc | Immunomodulating azalides |
| CN121038797A (zh) | 2023-03-22 | 2025-11-28 | 艾比恩多制药有限责任公司 | 用于治疗嗜酸性粒细胞相关疾病的阿奇霉素衍生物 |
| GB202404587D0 (en) | 2024-03-28 | 2024-05-15 | Epiendo Pharmaceuticals Ehf | Chemical forms |
| GB202412461D0 (en) | 2024-08-23 | 2024-10-09 | Epiendo Pharmaceuticals Ehf | Medial use |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3725385A (en) | 1970-11-02 | 1973-04-03 | Abbott Lab | Process for the demethylation of 3-amino macrolides |
| HRP20010018A2 (en) * | 2001-01-09 | 2002-12-31 | Pliva D D | Novel anti-inflammatory compounds |
| AU2003219770B2 (en) * | 2002-02-15 | 2008-10-09 | Merckle Gmbh | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| RU2330858C2 (ru) | 2002-07-08 | 2008-08-10 | Глаксомитклайн Истраживацки Центар Загреб Д.О.О. | Новые соединения, составы и способы лечения воспалительных заболеваний и состояний |
| ITMI20022292A1 (it) | 2002-10-29 | 2004-04-30 | Zambon Spa | 9a-azalidi ad attivita' antiinfiammatoria. |
| GB0310984D0 (en) * | 2003-05-13 | 2003-06-18 | Glaxo Group Ltd | Novel compounds |
| US7767797B1 (en) * | 2004-09-30 | 2010-08-03 | Synovo Gmbh | Macrocyclic compounds and methods of use thereof |
| PT1851236E (pt) | 2005-01-13 | 2010-10-25 | Glaxosmithkline Zagreb | Macrólidos com actividade anti-inflamatória |
| EP1841776B1 (en) * | 2005-01-13 | 2008-12-31 | GlaxoSmithKline istrazivacki centar Zagreb d.o.o. | Decladinosyl-macrolides with anti-inflammatory activity |
| CN1837225A (zh) | 2005-08-23 | 2006-09-27 | 济南思创生物技术有限公司 | 阿奇霉素衍生物及其制法和药物应用 |
| RU2455308C2 (ru) | 2006-05-01 | 2012-07-10 | Тайсо Фармасьютикал Ко., Лтд. | Макролидные производные |
| CN101074251B (zh) * | 2007-06-22 | 2011-06-15 | 山东大学 | 阿奇霉素4＂-氨甲酸酯衍生物、制备方法及其药物组合物 |
| WO2009006403A2 (en) * | 2007-06-29 | 2009-01-08 | Georgia Tech Research Corporation | Non-peptide macrocyclic histone deacetylase (hdac) inhibitors and methods of making and using thereof |
| WO2010086351A1 (en) * | 2009-01-30 | 2010-08-05 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | 3'-n-substituted 9-deoxo-9a-methyl-9a-aza-homoerythromycin having antimalarial activity |
| CA2814333A1 (en) * | 2010-10-10 | 2012-04-19 | Synovo Gmbh | Anti-inflammatory macrolides |
| GB201105633D0 (en) * | 2011-04-01 | 2011-05-18 | Norbrook Lab Ltd | Antibotic compounds |
| EP2831083A4 (en) * | 2012-03-27 | 2016-03-09 | Michael W Burnet | INFLAMMATORY MAKROLIDE |
| AU2014252462A1 (en) | 2013-04-10 | 2015-10-01 | Probiotic Pharmaceuticals Aps | Azithromycin antimicrobial derivatives with non-antibiotic pharmaceutical effect |
| GB201520419D0 (en) | 2015-11-19 | 2016-01-06 | Epi Endo Pharmaceuticals Ehf | Compounds |
-
2015
- 2015-11-19 GB GBGB1520419.1A patent/GB201520419D0/en not_active Ceased
-
2016
- 2016-11-21 KR KR1020247035784A patent/KR20240157138A/ko active Pending
- 2016-11-21 JP JP2018526129A patent/JP6849896B2/ja active Active
- 2016-11-21 KR KR1020187017001A patent/KR102724114B1/ko active Active
- 2016-11-21 HR HRP20201246TT patent/HRP20201246T1/hr unknown
- 2016-11-21 CN CN201680067151.6A patent/CN108290919B/zh active Active
- 2016-11-21 RS RS20200947A patent/RS60698B1/sr unknown
- 2016-11-21 WO PCT/EP2016/078360 patent/WO2017085329A1/en not_active Ceased
- 2016-11-21 CN CN202210535850.6A patent/CN114933620B/zh active Active
- 2016-11-21 LT LTEP16804720.7T patent/LT3377511T/lt unknown
- 2016-11-21 DK DK16804720.7T patent/DK3377511T3/da active
- 2016-11-21 EP EP16804720.7A patent/EP3377511B1/en active Active
- 2016-11-21 US US15/777,223 patent/US10723752B2/en active Active
- 2016-11-21 SM SM20200426T patent/SMT202000426T1/it unknown
- 2016-11-21 HU HUE16804720A patent/HUE050307T2/hu unknown
- 2016-11-21 EP EP20172534.8A patent/EP3708573A1/en active Pending
- 2016-11-21 ES ES16804720T patent/ES2810703T3/es active Active
- 2016-11-21 SI SI201630881T patent/SI3377511T1/sl unknown
- 2016-11-21 PL PL16804720T patent/PL3377511T3/pl unknown
- 2016-11-21 CA CA3005088A patent/CA3005088A1/en active Pending
- 2016-11-21 PT PT168047207T patent/PT3377511T/pt unknown
-
2020
- 2020-06-18 US US16/904,593 patent/US11236120B2/en active Active
- 2020-08-12 CY CY20201100750T patent/CY1123418T1/el unknown
-
2021
- 2021-02-09 JP JP2021019109A patent/JP7256558B2/ja active Active
- 2021-12-15 US US17/551,223 patent/US12049477B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12049477B2 (en) | Azithromycin derivatives with epithelial barrier enhancement properties | |
| CN106232617B (zh) | 多粘菌素衍生物及其在与不同抗生素的联合疗法中的用途 | |
| JP5805389B2 (ja) | 非経口用抗菌剤 | |
| CA2676061A1 (en) | Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof | |
| CN116496318A (zh) | 一种杂环衍生物及其组合物和药学上的应用 | |
| KR20110099791A (ko) | 항염증 마크롤리드 | |
| JP2018529696A (ja) | ヒドロキシアルキルチアジアゾール誘導体 | |
| CN103965273A (zh) | 一种大环内酯类化合物 | |
| CN101117336A (zh) | 7-(4-肟基-3-氨基-1-哌啶基)喹啉羧酸衍生物及其制备方法 | |
| EP4683641A1 (en) | Azithromycin derivatives for use in the treatment of eosinophil-related diseases | |
| JP2018510190A (ja) | 複素環式化合物及びそれらの細菌感染症の予防または治療のための使用 | |
| HK40037271A (en) | Azithromycin derivatives with epithelial barrier enhancement properties | |
| HK1255270B (en) | Azithromycin derivatives with epithelial barrier enhancement properties | |
| JP2020506198A (ja) | 新規な複素環化合物と、細菌感染症の予防または治療におけるその利用 | |
| CN112218858B (zh) | 2,6-二氨基-3,4-二氢嘧啶-4-酮衍生物及其在治疗中的用途 | |
| JP2011518799A (ja) | ２’−ｏ，３’−ｎ−橋かけマクロライド | |
| US20090203585A1 (en) | Capreomycin derivatives and their use as antibacterials | |
| CN101100468A (zh) | 多利培南水合物结晶及其制备方法 | |
| WO2000042041A1 (en) | Carbapenem ester compounds | |
| HK1230601A1 (en) | Pyrazine compounds |